  | Beaudart, C., Tilquin, N., Abramowicz, P., Baptista, F., Peng, D. J., de Souza Orlandi, F., Drey, M., Dzhus, M., Fábrega-Cuadros, R., Fernandez-Garrido, J., Laurindo, L. F., Gasparik, A.-I., Geerinck, A., Emin, G., Iacob, S., Kilaitė, J., Kumar, P., Lee, S.-C., Lou, V. W. Q., ... Bruyère, O. (15 December 2023). Quality of life in sarcopenia measured with the SarQoL questionnaire: A meta-analysis of individual patient data. Maturitas, 180, 107902. doi:10.1016/j.maturitas.2023.107902  Peer Reviewed verified by ORBi |
 | Brabant, C., Geerinck, A., BEAUDART, C., Tirelli, E., Geuzaine, C., & BRUYERE, O. (15 March 2022). Exposure to magnetic fields and childhood leukemia: a systematic review and meta-analysis of case-control and cohort studies. Reviews on Environmental Health, online first. doi:10.1515/reveh-2021-0112 Peer Reviewed verified by ORBi |
 | Locquet, M., Sanchez Rodriguez, M. D. C., Bruyère, O., Geerinck, A., Lengele, L., Reginster, J.-Y., & Beaudart, C. (2022). Intrinsic Capacity Defined Using Four Domains and Mortality Risk: A 5-Year Follow-Up of the SarcoPhAge Cohort. The journal of nutrition, health & aging, 26 (1), 23-29. doi:10.1007/s12603-021-1702-7 Peer reviewed |
 | Geerinck, A., Locquet, M., Hiligsmann, M., Reginster, J.-Y., Bruyère, O., & Beaudart, C. (2022). Patients' preferences for quality-of-life aspects in sarcopenia: a best-worst scaling study. European Geriatric Medicine, 13 (2), 483-91. doi:10.1007/s41999-021-00563-8 Peer reviewed |
 | Geerinck, A., Demián, M.-B., Beaudart, C., & Gasparik, A.-I. (2022). Validation of the Hungarian Version of the SarQoL® Questionnaire and Its Association with the SARC-F Screening Tool. Journal of Frailty and Aging, 11 (3), 267 - 273. doi:10.14283/jfa.2021.53 Peer Reviewed verified by ORBi |
 | Geerinck, A., Beaudart, C., Reginster, J.-Y., Wojszel, Z. B., De Souza Orlandi, F., Bahat, G., Erdogan, T., Montero-Errasquin, B., Alekna, V., & Bruyère, O. (2022). Measurement properties of the Short Form Sarcopenia Quality of Life (SF-SARQOL) Questionnaire in an international dataset. Osteoporosis International, 32 (Suppl 1), 249. Peer Reviewed verified by ORBi |
 | Geerinck, A. (2021). Measuring quality of life in sarcopenia : Evaluation of the clinimetric properties of the SarQoL® questionnaire and its short form [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/262863 |
 | Geerinck, A., Locquet, M., Bruyère, O., Reginster, J.-Y., & Beaudart, C. (2021). Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL(®) questionnaire. Journal of Cachexia, Sarcopenia and Muscle, 12 (2), 319-330. doi:10.1002/jcsm.12687 Peer Reviewed verified by ORBi |
 | Geerinck, A., Locquet, M., Reginster, J.-Y., Bruyère, O., & Beaudart, C. (2021). Discriminative power of the Sarcopenia Quality of Life (SarQoL) questionnaire with the EWGSOP2 criteria [letter to the editor]. Journal of Frailty and Aging, 10 (2), 193-194. Peer Reviewed verified by ORBi |
 | Meuris, C., Kremer, C., Geerinck, A., Locquet, M., Bruyère, O., Defêche, J., Meex, C., Hayette, M.-P., Duchene, L., Dellot, P., Azarzar, S., Maréchal, N., Sauvage, A.-S., Frippiat, F., Giot, J.-B., Léonard, P., Fombellida, K., Moutschen, M., Durkin, K., ... Darcis, G. (2021). Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium. JAMA Network Open, 4 (10), 2128757. doi:10.1001/jamanetworkopen.2021.28757 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Beaudart, C., Al-Daghri, N., Avouac, B., Bauer, J., Bere, N., Bruyère, O., Cerreta, F., Cesari, M., Rosa, M. M., Cooper, C., Cruz Jentoft, A. J., Dennison, E., Geerinck, A., Gielen, E., Landi, F., Laslop, A., Maggi, S., Prieto Yerro, M. C., ... Fielding, R. A. (2021). Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults. Aging Clinical and Experimental Research, 33, 3-17. doi:10.1007/s40520-020-01663-4 Peer Reviewed verified by ORBi |
 | Geerinck, A., Beaudart, C., Reginster, J.-Y., Locquet, M., Monseur, C., GILLAIN, S., & Bruyère, O. (2021). Development and validation of a short version of the Sarcopenia Quality of Life questionnaire: the SF‑SarQoL. Quality of Life Research, 30 (8), 2349-2362. doi:10.1007/s11136-021-02823-3 Peer Reviewed verified by ORBi |
 | Geerinck, A., Dawson-Hughes, B., Beaudart, C., Locquet, M., Reginster, J.-Y., & Bruyère, O. (2021). Assessment of the performance of the SarQoL questionnaire in screening for sarcopenia in older people. Aging Clinical and Experimental Research, 33, 2149-2155. doi:10.1007/s40520-021-01913-z Peer Reviewed verified by ORBi |
 | Beaudart, C., Lengele, L., Leclercq, V., Geerinck, A., Sanchez Rodriguez, M. D. C., Bruyère, O., & Reginster, J.-Y. (December 2020). Symptomatic Efficacy of Pharmacological Treatments for Knee Osteoarthritis: A Systematic Review and a Network Meta‑Analysis with a 6‑Month Time Horizon. Drugs, 80 (18), 1947-1959. doi:10.1007/s40265-020-01423-8 Peer Reviewed verified by ORBi |
  | Geerinck, A. (December 2020). Overview of dissertation project [Paper presentation]. Journée des doctorants en Santé Publique. |
 | Geerinck, A., Reginster, J.-Y., Locquet, M., Monseur, C., Gillain, S., Bruyère, O., & Beaudart, C. (December 2020). Clinimetric properties of the newly developed short form sarcopenia quality of life (SF-SarQoL) questionnaire [Poster presentation]. Society on Sarcopenia, Cachexia and Wasting Disorders conference. |
 | Geerinck, A., Beaudart, C., Salvan, Q., Van Beveren, J., D'Hooghe, P., Bruyère, O., & Kaux, J.-F. (June 2020). French translation and validation of the Cumberland Ankle Instability Tool, an instrument for measuring functional ankle instability. Foot and Ankle Surgery, 26 (4), 391-397. doi:10.1016/j.fas.2019.05.002 Peer Reviewed verified by ORBi |
 | Geerinck, A., Beaudart, C., Locquet, M., Reginster, J.-Y., & Bruyère, O. (March 2020). Association between frailty and quality of life measured with the SarQoL®, SF-36 and EQ-5D questionnaires in older people from the SarcoPhAge cohort [Poster presentation]. International Conference on Frailty and Sarcopenia Research, Toulouse, France. |
 | Matijevic, R., BEAUDART, C., BRUYERE, O., Djurdjevic, A., Hrnjakovic, O., Harhaji, V., Savic, A., & Geerinck, A. (2020). Evaluation of factors associated with quality of life in older people. Osteoporosis International, 31 (S1), 370-371. Peer Reviewed verified by ORBi |
 | Geerinck, A., Bruyère, O., Locquet, M., Gillain, S., Monseur, C., Reginster, J.-Y., & Beaudart, C. (2020). Development of a short version of the sarcopenia quality of life (SARQOL®) questionnaire. Osteoporosis International, 31 (S1), 450-451. Peer Reviewed verified by ORBi |
 | Matijević, R., Hrnjaković, O., Đurđević, A., Geerinck, A., Beaudart, C., Bruyère, O., Dulić, O., Harhaji, V., & Rašović, P. (2020). Translation and psychometric performance of the Serbian version of the Sarcopenia Quality of Life (SarQoL®) questionnaire. Srpski Arhiv za Celokupno Lekarstvo, 148 (11-12), 742-748. doi:10.2298/SARH200924114M Peer Reviewed verified by ORBi |
 | Beaudart, C., Bruyère, O., Geerinck, A., Hajaoui, M., Scafoglieri, A., Perkisas, S., Bautmans, I., Gielen, E., Reginster, J.-Y., & Buckinx, F. (2020). Equation models developed with bioelectric impedance analysis tools to assess muscle mass: A systematic review. Clinical Nutrition ESPEN, 35, 47-62. doi:10.1016/j.clnesp.2019.09.012 Peer reviewed |
 | Beaudart, C., Lengele, L., Geerinck, A., Leclercq, V., Sanchez Rodriguez, M. D. C., Bruyère, O., & Reginster, J.-Y. (2020). Efficacy of symptomatic treatments for knee OA: a systematic review and network meta-analysis with a 6-month time-horizon. Osteoporosis International, 31 (S1), 56. Peer Reviewed verified by ORBi |
 | Geerinck, A., Beaudart, C., Locquet, M., Reginster, J.-Y., & Bruyère, O. (2020). Association between SARC-F and quality of life measured by SARQOL® questionnaire in older, community-dwelling subjects friom the SarcoPhAge cohort. Osteoporosis International, 31 (S1), 451. Peer Reviewed verified by ORBi |
 | Geerinck, A., Locquet, M., Bruyère, O., Reginster, J.-Y., & Beaudart, C. (2020). Evaluating quality of life in frailty: applicability and psychometric properties of the SARQOL® questionnaire. Osteoporosis International, 31 (S1), 450. Peer Reviewed verified by ORBi |
 | Matijevic, R., BEAUDART, C., BRUYERE, O., Djurdjevic, A., Hrnjakovic, O., Harhaji, V., Savic, A., & Geerinck, A. (2020). Performance of the SARC-F screening tool in a Serbian cohort. Osteoporosis International, 31 (S1), 371. Peer Reviewed verified by ORBi |
 | Dzhus, M., Dzhus, M., Masnyi, M., Kulyk, M., Mostbauer, H., Ivashkivsky, O., Boyko, Y., Cherchenko, K., Geerinck, A., Reginster, J.-Y., Bruyère, O., & Beaudart, C. (2020). Cross-sectional evaluation of the sarcopenia quality of life (Sarqol) questionnaire: Translation and validation of its psychometric properties. Annals of Geriatric Medicine and Research, 24 (2), 139-147. doi:10.4235/AGMR.20.0020 Peer Reviewed verified by ORBi |
| Geerinck, A., Beaudart, C., Dardenne, N., Reginster, J.-Y., & Bruyère, O. (December 2019). An exploration of the structural validity of the Sarcopenia Quality of Life (SarQoL) questionnaire with exploratory and confirmatory factor analysis [Paper presentation]. Journée des doctorants en Santé Publique. |
 | Honvo, G., Bruyère, O., Geerinck, A., Veronese, N., & Reginster, J.-Y. (July 2019). Effect of oral chondroitin on pain in patients with knee osteoarthritis: outcomes of a comprehensive meta-analysis exploring inconsistencies in randomised, placebo-controlled trials. Osteoporosis International, 30 (S2), 175. Peer Reviewed verified by ORBi |
 | Honvo, G., Reginster, J.-Y., Rannou, F., Rygaert, X., Geerinck, A., Rabenda, V., McAlindon, T., Charles, A., Fuggle, N. R., Cooper, C., Curtis, E. M., Arden, N., Avouac, B., & Bruyère, O. (July 2019). Safety of an intra-articular hyaluronic acid injections in osteoarthritis: outcomes of a systematic review and meta-analysis. Osteoporosis International, 30 (S2), 290. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Honvo, G., Geerinck, A., & Bruyère, O. (July 2019). Efficacy and tolerance of pharmaceutical-grade chondroitin sulfate: what does evidence-based medicine say? Osteoporosis International, 30 (S2), 779. Peer Reviewed verified by ORBi |
 | Honvo, G., Bruyère, O., Geerinck, A., Veronese, N., & Reginster, J.-Y. (July 2019). Effect of oral chondroitin sulfate on functional status in patients with knee osteoarthritis: outcomes of a comprehensive meta-analysis exploring inconsistencies in randomized, placebo-controlled trials. Osteoporosis International, 30 (S2), 452-S453. Peer Reviewed verified by ORBi |
 | Geerinck, A., Alekna, V., Beaudart, C., Bautmans, I., Cooper, C., De Souza Orlandi, F., Konstantynowicz, J., Monterro-Errasquin, B., Topinkova, E., Tsekoura, M., Reginster, J.-Y., & Bruyère, O. (29 April 2019). Standard error of measurement and smallest detectable change of the Sarcopenia Quality of Life (SarQoL) questionnaire: An analysis of subjects from 9 validation studies. PLoS ONE, 14 (4). doi:10.1371/journal.pone.0216065 Peer Reviewed verified by ORBi |
 | Honvo, G., Bruyère, O., Geerinck, A., & Reginster, J.-Y. (April 2019). Symptomatic efficacy of oral chondroitin sulfate in knee osteoarthritis: A systematic review and meta-analysis of randomized, placebo-controlled trials. Osteoarthritis and Cartilage, 27 (Suppl 1), 498–S499. doi:10.1016/j.joca.2019.02.558 Peer Reviewed verified by ORBi |
 | Honvo, G., Reginster, J.-Y., Geerinck, A., & Bruyère, O. (April 2019). Safety of oral chondroitin sulfate in the management of knee osteoarthritis: results of a new meta-analysis of randomized. Placebo-controlled trials. Osteoarthritis and Cartilage, 27 (Suppl 1), 499. doi:10.1016/j.joca.2019.02.559 Peer Reviewed verified by ORBi |
 | Honvo, G., Bruyère, O., Geerinck, A., Veronese, N., & Reginster, J.-Y. (2019). Efficacy of chondroitin sulfate in patients with knee osteoarthritis: a comprehensive meta-analysis exploring inconsistencies in randomized, placebo-controlled trials. Advances in Therapy, 36 (5), 1085-99. doi:10.1007/s12325-019-00921-w Peer Reviewed verified by ORBi |
 | Alekna, V., Kilaite, J., Tamulaitiene, M., Geerinck, A., Mastaviciute, A., Bruyère, O., Reginster, J.-Y., & Beaudart, C. (2019). Validation of the Lithuanian version of sarcopenia‑specific quality of life questionnaire (SarQoL®). European Geriatric Medicine, 10, 761-767. doi:10.1007/s41999-019-00208-x Peer reviewed |
 | Honvo, G., Reginster, J.-Y., Rannou, F., Rygaert, X., Geerinck, A., Rabenda, V., McAlindon, T., Charles, A., Fuggle, N., Cooper, C., Curtis, E., Arden, N., Avouac, B., & Bruyère, O. (2019). Safety of intra-articular hyaluronic acid injections in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs and Aging, 36 (suppl 1), 101-127. doi:10.1007/s40266-019-00657-w Peer Reviewed verified by ORBi |
 | Geerinck, A., Beaudart, C., Dardenne, N., Reginster, J.-Y., & Bruyère, O. (2019). An exploration of the structural validity of the sarcopenia quality of life (SARQOL®) questionnaire with exploratory and confirmatory factor analysis. Osteoporosis International, 30 (S2), 537. Peer Reviewed verified by ORBi |
 | Honvo, G., Leclercq, V., Geerinck, A., Thomas, T., Veronese, N., Charles, A., Rabenda, V., Beaudart, C., Cooper, C., Reginster, J.-Y., & Bruyère, O. (2019). Safety of topical non-steroidal anti-inflammatory drugs in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs and Aging, 36 (suppl 1), 45-64. doi:10.1007/s40266-019-00661-0 Peer Reviewed verified by ORBi |
 | Honvo, G., Reginster, J.-Y., Rabenda, V., Geerinck, A., Mkinsi, O., Charles, A., Rizzoli, R., Cooper, C., Avouac, B., & Bruyère, O. (2019). Safety of symptomatic slow-acting drugs for osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs and Aging, 36 (suppl 1), 65-99. doi:10.1007/s40266-019-00662-z Peer Reviewed verified by ORBi |
 | Geerinck, A., Beaudart, C., Reginster, J.-Y., & Bruyère, O. (2019). Comparison of the psychometric properties of the SarQoL® questionnaire with the EWGSOP and EWGSOP2 criteria for sarcopenia. Osteoporosis International, 30 (S2), 179. Peer Reviewed verified by ORBi |
 | Geerinck, A., Scheppers, A., Beaudart, C., Bruyère, O., Vandenbussche, W., Bautmans, R., Delye, S., & Bautmans, I. (December 2018). Translation and validation of the Dutch SarQoL, a quality of life questionnaire specific to sarcopenia. Journal of Musculoskeletal and Neuronal Interactions, 18(4), 463-472. Peer Reviewed verified by ORBi |
| Geerinck, A., Beaudart, C., Bautmans, I., Cooper, C., De Souza Orlandi, F., Konstantynowicz, J., Monterro-Errasquin, B., Topinkova, E., Tsekoura, M., Reginster, J.-Y., & Bruyère, O. (13 November 2018). Standard error of measurement and smallest detectable change of the SarQoL questionnaire: an analysis of subjects from 8 validation studies [Poster presentation]. European congress of the International society for Pharmaeconomics and Outcomes Research (ISPOR), Barcelona, Spain. |
 | Geerinck, A., Bruyère, O., Locquet, M., Reginster, J.-Y., & Beaudart, C. (November 2018). Evaluation of the responsiveness of the SarQoL® questionnaire, a patient-reported outcome measure specific to sarcopenia. Advances in Therapy, 35, 1842-1858. doi:10.1007/s12325-018-0820-z Peer Reviewed verified by ORBi |
| Geerinck, A., Beaudart, C., Bautmans, I., Cooper, C., De Souza Orlandi, F., Konstantynowicz, J., Monterro-Errasquin, B., Topinkova, E., Tsekoura, M., Reginster, J.-Y., & Bruyère, O. (11 October 2018). Standard error of measurement and smallest detectable change of the SarQoL questionnaire: an analysis of subjects from 8 validation studies [Paper presentation]. 14th International Congress of the European Geriatric Medicine Society, Berlin, Germany. |
 | GEERINCK, A., Bruyère, O., Locquet, M., Reginster, J.-Y., & Beaudart, C. (21 April 2018). Evaluation of the responsiveness of a patient-reported outcome measure specific to sarcopenia: the SarQoL questionnaire [Poster presentation]. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Krakow, Poland. |
 | Honvo, G., Leclercq, V., GEERINCK, A., Rabenda, V., Beaudart, C., Cooper, C., Reginster, J.-Y., & Bruyère, O. (April 2018). Adverse events associated with topical non-steroidal anti-inflammatory drugs (NSAIDS) in osteoarthritis: a systematic review and meta-analysis of randomized, placebo-controlled trials. Osteoporosis International, 29 S1, 550. Peer Reviewed verified by ORBi |
 | GEERINCK, A., Bruyère, O., Locquet, M., Reginster, J.-Y., & Beaudart, C. (April 2018). Evaluation of the responsiveness of the SARQOL® questionnaire: results from the SarcoPhAge study. Osteoporosis International, 29 S1, 300. Peer Reviewed verified by ORBi |
 | Honvo, G., Rabenda, V., GEERINCK, A., Cooper, C., Reginster, J.-Y., & Bruyère, O. (April 2018). Adverse events associated with symptomatic slow-acting drugs in osteoarthritis (SYSADOAS): a systematic review and stratified meta-analysis of randomized, placebo-controlled trials. Osteoporosis International, 29 S1, 549-550. Peer Reviewed verified by ORBi |
 | GEERINCK, A., Scheppers, A., Beaudart, C., Bruyère, O., Vandenbussche, W., Bautmans, R., Delye, S., & Bautmans, I. (February 2018). Translation and validation of the psychometric properties of the Dutch version of the SarQoL®, a quality of life questionnaire specific to sarcopenia [Paper presentation]. Winter Meeting, Ostende, Belgium. |
Geerinck, A. (2018). Standard error of measurement and smallest detectable change of the SarQoL questionnaire: a pooled analysis of subjects from 8 validation studies. |
 | Beaudart, C., Rabenda, V., Simmons, M., Geerinck, A., Araujo De Carvalho, I., Reginster, J.-Y., Amuthavalli Thiyagarajan, J., & Bruyère, O. (2018). Effects of protein, essential amino acids, B-Hydroxy B-Methylbutyrate, creatine, Dehydroepiandrosterone and fatty acid supplementation on muscle mass, muscle strength and physical performance in older people aged 60 years and over. A systematic review of the litterature. Journal of Nutrition, Health and Aging, 22 (1), 117-130. doi:10.1007/s12603-017-0934-z Peer Reviewed verified by ORBi |
 | Beaudart, C., Reginster, J.-Y., Geerinck, A., Locquet, M., & Bruyère, O. (2017). Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia. Expert Review of Pharmacoeconomics and Outcomes Research, 17 (4), 335-341. doi:10.1080/14737167.2017.1360768 Peer Reviewed verified by ORBi |